Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToNetincome,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,currency,esgPopulated,tradeable,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,exchange,marketState,market,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,IMMG,16603,151744992,5694,,-44093,,-44093,38399,0,-44093,-44093,,,,,,0,0,44093,0,0,,-44093,-44093,5740,1888375,68469,22343,90812,151745,-2017777,53687,68469,28052,57020,12202,-32487.0,-1500.0,-1500.0,2500.0,-73448.0,-71948.0,2132.0,,,-11449,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.0001,1.0,1.0E-4 - 0.0099,-0.0097,-0.979798,0.0001,0.0099,-0.012,0.0,2.0E-4 - 2.0E-4,0.0002,finmb_225085907,Other OTC,Immage Biotherapeutics Corp.,USD,1254,471,0.0,0.000109090906,9.090909e-05,0.8333333,0.00010220588,9.7794116e-05,0.95683455,30348,15,America/New_York,EDT,-14400000,4,PNK,PRE,us_market,IMMAGE BIOTHERAPEUTICS CORP,0.0002,1630083451,0.0,0.0002,0.0002,0.0002,800,56.95,,,0.0099,0.0001,0.0001,0.0001,1.25k,471,151.74M,,45.74M,69.86%,0.00%,,,,,,,,,,,,,,,,"Aug 30, 2016","Feb 27, 2017",0.00%,0.00%,-496.11%,"-1,133.57%",,,,,-1.82M,-1.83M,-0.0120,,53.69k,0,56.27k,251.83,0.83,0.00,-274.08k,-1.14M,Value,20817,,3,"Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.",Bethesda,866-692-2939,MD,1483142400,United States,http://www.immagebio.com,86400,10411 Motor City Drive,,Suite 750
t-1,IMMG,60617,151744992,1625066,,-1670852,,-1670852,45786,0,-1670852,-1670852,,,,,,0,0,1670852,0,0,,-1670852,-1670852,5819,1888375,102456,66436,168892,151745,-1973684,127135,102456,30105,132968,48189,45140.0,1500.0,1500.0,2500.0,-69580.0,-71080.0,2132.0,1550000.0,,30512,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.0001,1.0,1.0E-4 - 0.0099,-0.0097,-0.979798,0.0001,0.0099,-0.012,0.0,2.0E-4 - 2.0E-4,0.0002,finmb_225085907,Other OTC,Immage Biotherapeutics Corp.,USD,1254,471,0.0,0.000109090906,9.090909e-05,0.8333333,0.00010220588,9.7794116e-05,0.95683455,30348,15,America/New_York,EDT,-14400000,4,PNK,PRE,us_market,IMMAGE BIOTHERAPEUTICS CORP,0.0002,1630083451,0.0,0.0002,0.0002,0.0002,800,56.95,,,0.0099,0.0001,0.0001,0.0001,1.25k,471,151.74M,,45.74M,69.86%,0.00%,,,,,,,,,,,,,,,,"Aug 30, 2016","Feb 27, 2017",0.00%,0.00%,-496.11%,"-1,133.57%",,,,,-1.82M,-1.83M,-0.0120,,53.69k,0,56.27k,251.83,0.83,0.00,-274.08k,-1.14M,Value,20817,,3,"Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.",Bethesda,866-692-2939,MD,1483142400,United States,http://www.immagebio.com,86400,10411 Motor City Drive,,Suite 750
t-2,IMMG,181390,151744992,17834,,-61996,,-61996,44162,0,-61996,-61996,,,,,,0,0,61996,0,0,,-61996,-61996,5898,343375,55816,187288,243104,146745,-302832,196715,55816,32158,205048,3049,-31.0,1500.0,1500.0,-8333.0,-68777.0,-68777.0,1583.0,1550000.0,,149232,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.0001,1.0,1.0E-4 - 0.0099,-0.0097,-0.979798,0.0001,0.0099,-0.012,0.0,2.0E-4 - 2.0E-4,0.0002,finmb_225085907,Other OTC,Immage Biotherapeutics Corp.,USD,1254,471,0.0,0.000109090906,9.090909e-05,0.8333333,0.00010220588,9.7794116e-05,0.95683455,30348,15,America/New_York,EDT,-14400000,4,PNK,PRE,us_market,IMMAGE BIOTHERAPEUTICS CORP,0.0002,1630083451,0.0,0.0002,0.0002,0.0002,800,56.95,,,0.0099,0.0001,0.0001,0.0001,1.25k,471,151.74M,,45.74M,69.86%,0.00%,,,,,,,,,,,,,,,,"Aug 30, 2016","Feb 27, 2017",0.00%,0.00%,-496.11%,"-1,133.57%",,,,,-1.82M,-1.83M,-0.0120,,53.69k,0,56.27k,251.83,0.83,0.00,-274.08k,-1.14M,Value,20817,,3,"Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.",Bethesda,866-692-2939,MD,1483142400,United States,http://www.immagebio.com,86400,10411 Motor City Drive,,Suite 750
t-3,IMMG,243856,151744992,9712,,-50859,,-50859,41147,0,-50859,-50859,,,,,,0,0,50859,0,0,,-50859,-50859,5428,343375,55847,249284,305131,146745,-240836,265492,55847,34211,265492,3080,-13734.0,-375000.0,1500.0,-8333.0,-62278.0,-62278.0,2315.0,1550000.0,375000.0,209645,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.0001,1.0,1.0E-4 - 0.0099,-0.0097,-0.979798,0.0001,0.0099,-0.012,0.0,2.0E-4 - 2.0E-4,0.0002,finmb_225085907,Other OTC,Immage Biotherapeutics Corp.,USD,1254,471,0.0,0.000109090906,9.090909e-05,0.8333333,0.00010220588,9.7794116e-05,0.95683455,30348,15,America/New_York,EDT,-14400000,4,PNK,PRE,us_market,IMMAGE BIOTHERAPEUTICS CORP,0.0002,1630083451,0.0,0.0002,0.0002,0.0002,800,56.95,,,0.0099,0.0001,0.0001,0.0001,1.25k,471,151.74M,,45.74M,69.86%,0.00%,,,,,,,,,,,,,,,,"Aug 30, 2016","Feb 27, 2017",0.00%,0.00%,-496.11%,"-1,133.57%",,,,,-1.82M,-1.83M,-0.0120,,53.69k,0,56.27k,251.83,0.83,0.00,-274.08k,-1.14M,Value,20817,,3,"Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.",Bethesda,866-692-2939,MD,1483142400,United States,http://www.immagebio.com,86400,10411 Motor City Drive,,Suite 750
